Picture of Nippon Shinyaku Co logo

4516 Nippon Shinyaku Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Momentum

Relative Strength (%)
1m-7.29%
3m-12.62%
6m-35.38%
1yr-35.68%
Volume Change (%)
10d/3m-28.85%
Price vs... (%)
52w High-26.39%
50d MA-0.82%
200d MA-7.97%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)8.84
PEG Ratio (f)n/a
EPS Growth (f)-12.87%
Dividend Yield (f)3.88%
Valuation (ttm)IndustryMarket
Price to Book Value0.87
Price to Tang. Book1.07
Price to Free Cashflow34.25
Price to Sales1.36
EV to EBITDA3.94

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital13.37%
Return on Equity12.76%
Operating Margin21.45%

Financial Summary

Year End 31st MarUnit202120222023202420252026E2027ECAGR / Avg
Total Revenue¥m121,859137,484144,175148,255160,232167,845176,8226.56%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+16.35+28.83-7.49+14.14+25.48-27.59+3.72n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202631st Mar 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of Nippon Shinyaku Co EPS forecast chart

Profile Summary

Nippon Shinyaku Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals and functional foods. The Company has two business segments. The Pharmaceutical Business segment conducts research and development in three focus areas: hematology, intractable and rare diseases (pulmonary arterial hypertension, muscular dystrophy, etc.), and urological and gynecological diseases. The Functional Food Business segment conducts research and development mainly in three categories: health food ingredients, quality-stabilizing preservatives, and protein preparations. Other businesses include business support, non-life insurance agency and life insurance solicitation, real estate rental, and educational support services.

Directors

Last Annual
March 31st, 2025
Last Interim
June 30th, 2025
Incorporated
September 23rd, 1919
Public Since
July 4th, 1949
No. of Shareholders
11,607
No. of Employees
2,243
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
67,378,645

4516 Share Price Performance

Upcoming Events for 4516

Q2 2026 Nippon Shinyaku Co Ltd Earnings Release

Q3 2026 Nippon Shinyaku Co Ltd Earnings Release

Similar to 4516

Picture of Astellas Pharma logo

Astellas Pharma

jp flag iconTokyo Stock Exchange

Picture of Astena Holdings Co logo

Astena Holdings Co

jp flag iconTokyo Stock Exchange

Picture of CanBas Co logo

CanBas Co

jp flag iconTokyo Stock Exchange

Picture of CellSeed logo

CellSeed

jp flag iconTokyo Stock Exchange

FAQ